South Africa and Europe point-of-care-testing (POCT) market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2023 to 2030 and is expected to reach USD 17,289.45 million by 2030 from USD 8,565.13 million in 2022.

The global healthcare industry is experiencing a paradigm shift toward decentralized and patient-centric care. At the center of this shift lies Point of Care Testing (POCT), a diagnostic approach that delivers immediate results at or near the patient’s location. South Africa and Europe are emerging as two important regions in the POCT landscape, each with distinct drivers and challenges shaping their markets.

South Africa is focused on improving access to healthcare amid high disease burdens, while Europe emphasizes innovation, regulatory frameworks, and early adoption of advanced diagnostic technologies. Both regions represent significant opportunities for companies, healthcare providers, and patients alike.

Point of care testing covers a wide range of applications, including blood glucose monitoring, infectious disease diagnostics, pregnancy testing, cardiac markers, and hematology. Its primary advantage is speed, enabling physicians and patients to make timely clinical decisions that can improve outcomes and reduce healthcare costs. With increasing awareness of preventive care, the demand for faster diagnostic methods, and growing government support for healthcare infrastructure, the South African and European POCT markets are gaining momentum.

Download full report here: https://www.databridgemarketresearch.com/reports/south-africa-and-europe-poct-market

Market Trends

Several trends define the current trajectory of the point of care testing market in South Africa and Europe.

In South Africa, the high prevalence of infectious diseases such as HIV, tuberculosis, and malaria continues to drive demand for rapid diagnostics. The government and international organizations are investing in programs that emphasize early detection and treatment, positioning POCT as a crucial tool in the country’s healthcare system. Another significant trend is the rising role of mobile health technologies. With limited access to advanced laboratory facilities in rural areas, portable and easy-to-use POCT devices are bridging the diagnostic gap and providing life-saving solutions in underserved communities.

In Europe, the market is shaped by advancements in molecular diagnostics and the integration of digital health tools. The COVID-19 pandemic accelerated the adoption of POCT across the continent, establishing a permanent role for rapid testing in healthcare delivery. Countries like Germany, the UK, and France are leading in the adoption of next-generation POCT devices that incorporate biosensors, microfluidics, and artificial intelligence. Additionally, Europe’s stringent regulatory frameworks, particularly under the In Vitro Diagnostic Regulation (IVDR), are influencing market strategies, compelling manufacturers to ensure compliance and enhance product reliability.

Another shared trend in both regions is the rise of consumer-driven healthcare. Patients are becoming more proactive in managing their health, leading to increased demand for self-testing kits for chronic diseases and lifestyle-related conditions. The convergence of diagnostics with telemedicine platforms further amplifies the adoption of POCT, allowing patients to connect test results with virtual consultations for faster clinical interventions.

Market Size

The South African point of care testing market is growing steadily, driven by the country’s need to combat widespread infectious diseases and improve healthcare access in rural areas. The market value is projected to expand over the next decade as the government and private healthcare providers adopt cost-effective diagnostic solutions. Investments from global healthcare companies are also fueling the availability of advanced POCT devices in the region, making diagnostics more affordable and accessible.

Europe, on the other hand, commands a much larger market size due to its robust healthcare infrastructure, higher expenditure on research and development, and early adoption of innovative technologies. The European market accounts for a significant share of the global POCT industry, with major growth attributed to chronic disease management, aging populations, and the rapid deployment of testing solutions during the pandemic. Market size is further supported by collaborations between healthcare providers, research institutes, and technology companies, accelerating innovation and commercialization.

Together, South Africa and Europe represent a diverse yet complementary POCT landscape, with one region emphasizing accessibility and disease control while the other focuses on innovation and regulatory compliance.

Market Share

In South Africa, infectious disease testing holds the largest share of the POCT market, reflecting the country’s urgent healthcare priorities. HIV and tuberculosis testing solutions dominate the sector, supported by extensive public health campaigns and international funding. Glucose monitoring is another major segment, fueled by the growing burden of diabetes in the country. Local manufacturers are also entering the space, though global players continue to dominate due to their advanced product portfolios and distribution networks.

In Europe, the market share is more evenly distributed across multiple POCT applications. Blood glucose monitoring remains a leading segment, driven by the high prevalence of diabetes, but infectious disease testing, cardiac markers, and oncology-related POCT devices are also significant contributors. Large multinational corporations such as Roche Diagnostics, Abbott, Siemens Healthineers, and bioMérieux dominate the European market, but startups and niche innovators are carving out opportunities with specialized technologies. The introduction of self-testing kits for COVID-19 dramatically expanded market reach, with continued demand for similar home-based diagnostics across other disease areas.

Market Growth

The growth trajectory of POCT in South Africa is strongly tied to the country’s evolving healthcare priorities. Rising government spending on healthcare infrastructure, combined with partnerships with non-governmental organizations, is creating a favorable environment for growth. The increasing incidence of chronic diseases, alongside infectious disease burdens, is diversifying the demand for POCT beyond its traditional focus. Growing awareness among patients about the benefits of early diagnosis is further accelerating adoption. The CAGR of the South African POCT market is expected to remain robust in the coming years.

Europe’s growth outlook is equally promising but driven by different factors. The emphasis on personalized medicine, preventive care, and digital integration is expanding the role of POCT in clinical pathways. Technological innovations, such as connected devices that sync test results with electronic health records, are boosting demand. Additionally, Europe’s focus on sustainability and cost efficiency in healthcare is encouraging providers to adopt POCT solutions that reduce hospital stays and laboratory expenses. The European POCT market is expected to sustain steady growth as healthcare systems adapt to an aging population and rising chronic disease rates.

Market Demand

Demand for POCT in South Africa stems from the pressing need to provide diagnostic services to populations that lack access to advanced laboratories. Rural and peri-urban communities particularly benefit from portable POCT devices, as they offer immediate results and reduce reliance on centralized facilities. The demand is also reinforced by government-led screening programs for infectious diseases, maternal health initiatives, and the growing diabetes population requiring routine glucose monitoring.

In Europe, demand is fueled by both healthcare providers and consumers. Hospitals and clinics are adopting POCT for faster patient management, while patients are increasingly seeking home-based diagnostic kits. The aging population, which requires frequent monitoring for chronic conditions, is a major driver of sustained demand. Additionally, the integration of POCT with telehealth platforms is creating new opportunities for patient engagement, particularly in countries with advanced digital health ecosystems.

Browse More Reports:

Global Barrier Resin Market
Global BB Cream Market
Global Bedtime Snacks Market
Global Beer Ingredients Market
Global Behavioral Rehabilitation Market
Global Beverage Containers Market
Global Bicycle Chain Market
Global Bioartificial Organ Manufacturing Market
Global Biobanking Market
Global Bio-Based Polypropylene (PP) Market
Global Biodegradable Tableware Market
Global Bioengineered Crop Market
Global Biomarker Technologies Market
Global Bioservices Market
Global Biotechnological Plant Breeding and CRISPR Plants Market

Market Future Insights

The future of point of care testing in South Africa and Europe appears promising, with innovation, accessibility, and patient-centric care at the forefront.

In South Africa, the focus will continue to be on expanding access to healthcare through affordable and portable diagnostics. Collaborations between global manufacturers and local stakeholders are likely to bring down costs and enhance availability. The integration of POCT with mobile health applications is expected to further transform disease management, particularly in remote areas. The long-term outlook emphasizes the role of POCT in strengthening public health responses to epidemics and chronic disease burdens.

In Europe, the future will be driven by technological sophistication and regulatory harmonization. The adoption of advanced molecular diagnostics, AI-driven POCT devices, and cloud-connected testing platforms will reshape how healthcare is delivered. The European market is expected to lead global innovation in this sector, setting standards for quality, safety, and digital integration. The growing preference for self-testing, supported by regulatory approvals and consumer confidence, will also redefine the relationship between patients and healthcare providers.

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research

US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975

Email:- [email protected]

South Africa and Europe Point of Care Testing Market, South Africa and Europe Point of Care Testing Market Trends, South Africa and Europe Point of Care Testing Market Growth, South Africa and Europe Point of Care Testing Market Demand, South Africa and Europe Point of Care Testing Market Size, South Africa and Europe Point of Care Testing Market Scope, South Africa and Europe Point of Care Testing Market Insights, South Africa and Europe Point of Care Testing Market Analysis,